期刊文献+

口服普萘洛尔联合激光治疗婴幼儿头面部血管瘤 被引量:5

Oral propranolol combined laser therapy for infants with craniofacial hemangioma
在线阅读 下载PDF
导出
摘要 目的观察口服普萘洛尔联合激光治疗婴幼儿头面部血管瘤的临床疗效及不良反应。方法选取20例婴幼儿头面部血管瘤,均不伴有瘤体破溃。入院后予心电图,心脏彩超检查,排除用药禁忌,予以口服普萘洛尔(2mg/kg·d),同时结合定期激光治疗。结果口服普萘洛尔72h内,瘤体的颜色、张力均有不同程度减轻。随访3~12个月,通过B超检查显示的病灶血流信号及瘤体大小的变化进行疗效评估。其中痊愈12例,显效8例,有效率100%。3例病人用药初期出现腹泻,予补液等对症处理后好转。其余无明显异常不良反应。结论口服普萘洛尔联合激光治疗婴幼儿头面部血管瘤,疗效显著且不良反应较少,是一种安全有效的治疗方法。 Objective The purpose is to observe clinical efficacy and adverse reactions of oral propranolol combined laser therapy for infants with craniofacial hemangioma.Methods Selected20cases of infant craniofacial hemangioma that tumors had not burst.Did electrocardiogram,cardiac ultrasound examination after admission to hospital.exclude the drug prohibition and oralled propranolol(2mg/kg d),combined with regular laser treatment.Result Oralled propranolol duing72hours,The color and tension of the tumor were reduced in different degrees Follow-up for3~12months,The results showed that the changes of the blood flow signal and the size of the tumor are evaluated.Among them,12cases were cured,8cases were developed,and the efficiency was100%.Three patients had diarrhea in the early days of the drug administration,and the symptoms improved after rehydration therapy.There was no obvious adverse reaction.Conclusion Oralling propranolol combined with laser is a safe and effective treatment for infants with craniofacial hemangioma.
作者 周一冲 姜润松 赵雄 ZHOU Yi-chong;JIANG Run-song;ZHAO Xiong(Dept of Burn and Plastic Surgery, The Children′s Hospital Zhejiang University School of Medicine,Zhejiang Province, 310052, China)
出处 《中国医疗美容》 2017年第11期24-26,共3页 China Medical Cosmetology
关键词 婴幼儿血管瘤 头面部 普萘洛尔 激光 Infant hemangioma Craniofacial Propranolol Laser beam
  • 相关文献

参考文献2

二级参考文献16

  • 1Metry D. Update on hemangiomas of infancy. Curt Opin Pediatr, 2004, 16:373-377.
  • 2Bennett ML, Fleiseher Jr AB, Chamlin SL, et al. Oral eortieosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol, 2001, 137 : 1208-1213.
  • 3Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alpha 2a therapy for life threatening hemangiomas of infancy. N Engl J Med, 1992, 326 : 1456-1463.
  • 4Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function-and life-threatening infantile hemangioma. Arch Pediatr, 2004, 11:99-107.
  • 5Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med, 2008, 358:2649-2651.
  • 6Waner M, Suen JY. A classification of congenital vascular lesions//Waner M, Suen JY. Hemangiomas and vascular malformations of the head and neck. New York: Wiley-Liss, 1999 : 1-12.
  • 7Achauer BM, Chang C J, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg, 1997, 99 : 1301-1308.
  • 8Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med, 2008, 359:2846.
  • 9Buekmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas : ease report of novel treatment. Laryngoscope, 2009, 119:2051-2054.
  • 10Gottschling S, Schneider G, Meyer S, et al. Two infants with life- threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer, 2006, 46:239-224.

共引文献130

同被引文献42

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部